A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer.
Hupperets
P S
PS
ten Velde
G P
GP
Bron
H
H
Schouten
L
L
Blijham
G H
GH
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000556:secondary*; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary*; D008875:Middle Aged; D014751:Vindesine / Q000008:administration & dosage
D005047:Etoposide; D014751:Vindesine